Received Oct 23, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | AMVB072A | — |
patient was administered with only the diluent (liquid part) an not the powder of the MENVEO; patient was administered with only the diluent (liquid part) an not the powder of the MENVEO; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate preparation of medication in a 16-year-old male patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVB072A, expiry date 30-APR-2026) for prophylaxis. On 30-SEP-2025, the patient received Menveo. On 30-SEP-2025, an unknown time after receiving Menveo, the patient experienced inappropriate preparation of medication (Verbatim: patient was administered with only the diluent (liquid part) an not the powder of the MENVEO) and inappropriate dose of vaccine administered (Verbatim: patient was administered with only the diluent (liquid part) an not the powder of the MENVEO). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date: 07-OCT-2025 The health care professional reported that a patient was administered with only the diluent (liquid part) an not the powder of the Menveo two vial vaccine (the vaccine was not reconstituted). The reporter needs guidance on this situation. The vaccination date, vaccine detail and patient demographics were obtained. The vaccine administration facility was the same as primary reporter.